A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer

To make an optimal treatment decision for early stage breast cancer, it is important to identify risk of recurrence. Here, we developed and validated a new prognostic model for predicting the risk of distant metastasis in patients with pN0-N1, hormone receptor-positive, HER2-negative (HR+/HER2−) bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Gyungyub, Kwon, Mi Jeong, Han, Jinil, Lee, Hee Jin, Lee, Se Kyung, Lee, Jeong Eon, Lee, Seon-Heui, Park, Sarah, Choi, Jong-Sun, Cho, Soo Youn, Ahn, Sei Hyun, Lee, Jong Won, Cho, Sang Rae, Moon, Youngho, Nam, Byung-Ho, Nam, Seok Jin, Choi, Yoon-La, Shin, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368569/
https://www.ncbi.nlm.nih.gov/pubmed/28350001
http://dx.doi.org/10.1038/srep45554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368569/
https://www.ncbi.nlm.nih.gov/pubmed/28350001
http://dx.doi.org/10.1038/srep45554

Ejemplares similares